S'abonner

Study Protocol, Sample Characteristics, and Loss to Follow-Up: The OPPERA Prospective Cohort Study - 25/11/13

Doi : 10.1016/j.jpain.2013.06.006 
Eric Bair , , , Naomi C. Brownstein , Richard Ohrbach §, Joel D. Greenspan ||, , ∗∗, Ronald Dubner ||, , ∗∗, Roger B. Fillingim ††, William Maixner , , ‡‡, Shad B. Smith , , Luda Diatchenko , , §§, ||||, Yoly Gonzalez §, Sharon M. Gordon ||, ∗∗, Pei-Feng Lim , , Margarete Ribeiro-Dasilva ¶¶, Dawn Dampier ∗∗∗, Charles Knott ∗∗∗, Gary D. Slade †††, ‡‡‡,
 Regional Center for Neurosensory Disorders, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 
 Department of Endodontics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 
 Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 
‡‡ Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 
††† Department of Dental Ecology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 
‡‡‡ Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 
§ Department of Oral Diagnostic Sciences, University at Buffalo, Buffalo, New York 
|| Department of Oral and Maxillofacial Surgery, University of Maryland School of Dentistry, Baltimore, Maryland 
 Department of Neural and Pain Sciences, University of Maryland School of Dentistry, Baltimore, Maryland 
∗∗ Brotman Facial Pain Center, University of Maryland School of Dentistry, Baltimore, Maryland 
†† Department of Community Dentistry and Behavioral Science, University of Florida, College of Dentistry, and Pain Research and Intervention Center of Excellence, Gainesville, Florida 
§§ Carolina Center for Genome Sciences, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 
|||| Department of Anesthesia, and Alan Edwards Centre for Resarch on Pain, McGill University, Montreal, Quebec, Canada 
¶¶ Department of Restorative Dental Sciences–Divison of Prosthodontics, University of Florida, College of Dentistry, Gainesville, Florida 
∗∗∗ Battelle Memorial Institute, Durham, North Carolina 

Address reprint requests to Gary D. Slade, BDSc, DDPH, PhD, Room 4501E, Koury Oral Health Sciences, UNC School of Dentistry, 385 South Columbia Street, CB#7455, Chapel Hill, NC 27599-7455.

Abstract

When studying incidence of pain conditions such as temporomandibular disorder (TMD), repeated monitoring is needed in prospective cohort studies. However, monitoring methods usually have limitations and, over a period of years, some loss to follow-up is inevitable. The OPPERA prospective cohort study of first-onset TMD screened for symptoms using quarterly questionnaires and examined symptomatic participants to definitively ascertain TMD incidence. During the median 2.8-year observation period, 16% of the 3,263 enrollees completed no follow-up questionnaires, others provided incomplete follow-up, and examinations were not conducted for one third of symptomatic episodes. Although screening methods and examinations were found to have excellent reliability and validity, they were not perfect. Loss to follow-up varied according to some putative TMD risk factors, although multiple imputation to correct the problem suggested that bias was minimal. A second method of multiple imputation that evaluated bias associated with omitted and dubious examinations revealed a slight underestimate of incidence and some small biases in hazard ratios used to quantify effects of risk factors. Although “bottom line” statistical conclusions were not affected, multiply-imputed estimates should be considered when evaluating the large number of risk factors under investigation in the OPPERA study.

Perspective

These findings support the validity of the OPPERA prospective cohort study for the purpose of investigating the etiology of first-onset TMD, providing the foundation for other papers investigating risk factors hypothesized in the OPPERA project.

Le texte complet de cet article est disponible en PDF.

Key words : Temporomandibular disorder, cohort studies, population statistics, epidemiologic methods, proportional hazards models


Plan


 Publication of this supplement was made possible with support of the National Institutes of Health grant U01DE017018 and T32ES007018. The OPPERA program also acknowledges resources specifically provided for this project by the participating institutions: Battelle Memorial Institute; University at Buffalo; University of Florida; University of Maryland; University of North Carolina at Chapel Hill.
 R.B.F. and G.D.S. are consultants and equity stock holders, and W.M. and L.D. are cofounders and equity stock holders in Algynomics, Inc, a company providing research services in personalized pain medication and diagnostics. Other authors declare no conflicts of interest.
 Supplementary data accompanying this article are available online at www.jpain.org and www.sciencedirect.com.


© 2013  American Pain Society. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 14 - N° 12S

P. T2-T19 - décembre 2013 Retour au numéro
Article précédent Article précédent
  • The OPPERA Study: Act Two
  • Samuel F. Dworkin
| Article suivant Article suivant
  • Signs and Symptoms of First-Onset TMD and Sociodemographic Predictors of Its Development: The OPPERA Prospective Cohort Study
  • Gary D. Slade, Eric Bair, Joel D. Greenspan, Ronald Dubner, Roger B. Fillingim, Luda Diatchenko, William Maixner, Charles Knott, Richard Ohrbach

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Elsevier s'engage à rendre ses eBooks accessibles et à se conformer aux lois applicables. Compte tenu de notre vaste bibliothèque de titres, il existe des cas où rendre un livre électronique entièrement accessible présente des défis uniques et l'inclusion de fonctionnalités complètes pourrait transformer sa nature au point de ne plus servir son objectif principal ou d'entraîner un fardeau disproportionné pour l'éditeur. Par conséquent, l'accessibilité de cet eBook peut être limitée. Voir plus

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2026 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.